Table 4. Sensitive analyses based on various exclusion criteria.
Studies,N | RRs,95%CIs | P value | P value for heterogeneity | I2(%) | |
---|---|---|---|---|---|
total | 14 | 1.05(0.96–1.15) | 0.291 | 0.000 | 82.8 |
Country | |||||
United States | 7 | 1.01(0.87–1.17) | 0.898 | 0.000 | 84.1 |
Europe | 5 | 1.13(0.95–1.35) | 0.168 | 0.001 | 79.7 |
Asia | 2 | 1.55(0.45–5.39) | 0.491 | 0.012 | 84.3 |
Gender | |||||
Female | 11 | 1.07(0.98–1.17) | 0.143 | 0.000 | 83.5 |
Male | 8 | 1.13(0.98–1.30) | 0.167 | 0.000 | 86.5 |
Effect measure | |||||
RRs | 10 | 1.02(0.91–1.15) | 0.712 | 0.000 | 83.9 |
ORs | 3 | 1.28(0.91–1.81) | 0.162 | 0.087 | 59.0 |
HRs | 1 | 0.98(0.93–1.04) | 0.479 | NA | NA |
Sample size | |||||
Large(cases ≥ 100) | 11 | 1.03(0.95–1.13) | 0.451 | 0.000 | 84.5 |
Small(cases <100) | 3 | 1.72(0.67–4.41) | 0.263 | 0.078 | 60.9 |
Adjustment for covariates | |||||
Yes | 8 | 0.96(0.83–1.10) | 0.529 | 0.000 | 75.0 |
No | 6 | 1.16(1.00–1.34) | 0.050 | 0.000 | 89.4 |
NOS score | |||||
High(≥5) | 13 | 1.02(0.94–1.12) | 0.600 | 0.000 | 80.8 |
Low(<5) | 1 | 1.26(1.12–1.42) | 0.000 | NA | NA |
Follow-up duration(years) | |||||
≥5 | 8 | 0.99(0.86–1.15) | 0.978 | 0.000 | 83.0 |
<5 | 3 | 1.11(0.99–1.25) | 0.075 | 0.000 | 87.1 |
NA | 2 | 1.64(0.52–5.16) | 0.394 | 0.030 | 78.8 |
HRs, hazard ratios, ORs, odds ratios, RRs, relative risks, CIs, confidence intervals; NA, not available.